132 related articles for article (PubMed ID: 21223798)
1. [Evolution pattern of the Runx3 gene 5'-CpG island methylation in human salivary gland adenoid cystic carcinoma].
Tan Z; Ling ZQ; Chen C; Xu JJ; Ge MH
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):907-12. PubMed ID: 21223798
[TBL] [Abstract][Full Text] [Related]
2. [RUNX3 expression and its methylation of 5'-CpG island in salivary gland adenoid cystic carcinoma cell lines ACC-2, ACC-3 and ACC-M].
Ge MH; Ling ZQ; Tan Z; Chen C; Zheng CM; Xu JJ; Zhu X
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3426-30. PubMed ID: 21223819
[TBL] [Abstract][Full Text] [Related]
3. Spreading of methylation within RUNX3 CpG island in gastric cancer.
Homma N; Tamura G; Honda T; Matsumoto Y; Nishizuka S; Kawata S; Motoyama T
Cancer Sci; 2006 Jan; 97(1):51-6. PubMed ID: 16367921
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
[TBL] [Abstract][Full Text] [Related]
5. Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis.
He JF; Ge MH; Zhu X; Chen C; Tan Z; Li YN; Gu ZY
Cancer Sci; 2008 Jul; 99(7):1334-40. PubMed ID: 18410404
[TBL] [Abstract][Full Text] [Related]
6. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
7. [Promoter methylation and expression of Runx3 gene in gastric cancer].
Li LY; Li JK; Shen Y; Yu L; Zhang JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
[TBL] [Abstract][Full Text] [Related]
10. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
12. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.
Holst VA; Marshall CE; Moskaluk CA; Frierson HF
Mod Pathol; 1999 Oct; 12(10):956-60. PubMed ID: 10530560
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
14. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S
Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
16. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of E-cadherin in adenoid cystic carcinoma of the salivary glands].
Lai FY; Zhang Q; Wu QL; Qing J; Cao Y
Ai Zheng; 2007 Sep; 26(9):1025-8. PubMed ID: 17927866
[TBL] [Abstract][Full Text] [Related]
18. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma.
Li J; El-Naggar A; Mao L
Cancer; 2005 Aug; 104(4):771-6. PubMed ID: 15959912
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation in promoter regions of cyclin-dependent kinase inhibitor genes in adenoid cystic carcinoma of the salivary gland.
Daa T; Kashima K; Kondo Y; Yada N; Suzuki M; Yokoyama S
APMIS; 2008 Jan; 116(1):21-6. PubMed ID: 18254776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
